Prot# AMIK-04-02: A Double-Blind, Placebo-Controlled, Parallel Group Phase 2 Dose-Ranging Study of Nebulized Amikacin Delivered Via the Pulmonary Drug Delivery System (PDDS) in Ventilated Patients with Nosocomial Pneumonia Due to Gram-Negative O

Project: Research project

Project Details

StatusFinished
Effective start/end date5/22/055/3/07

Funding

  • PPD Development (AMIK-04-02)
  • Aerogen, Inc. (AMIK-04-02)